0 items USD 0.00Search
- Did you mean
- dystrophy sulfate
Your search for "atrophy sulfate" gave back 4550 results.
Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Spinal Muscular Atrophy market was valued at US$ 1400 million in 2022 and is anticipated to reach US$ 2573.5 million by 2029,...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
Spinal Muscular Atrophy (SMA), also known as spinal muscular atrophy, is a type of disease in which the degeneration of motor neurons in the anterior...
颁补迟补濒辞驳:听
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Multiple System Atrophy Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
SBMA, mainly manifested as systemic muscle atrophy, paralysis and systemic muscle bundle tremor, patients with systemic muscle weakness, especially...
颁补迟补濒辞驳:听
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Postmenopausal Vaginal Atrophy (PVA) Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
Spinal muscular atrophy is a genetic disorder characterized by weakness and wasting (atrophy ) in muscles used for movement (skeletal muscles). It is...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
A detection method for Spinal Muscular Atrophy Highlights The global Spinal Muscular Atrophy Genetic Detection market was valued at US$ million in...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
Spinal Muscular Atrophy (SMA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
颁补迟补濒辞驳:听
Global Markets Direct
March 2022
Price: USD 2,000.00
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Global Markets Direct
February 2020
Price: USD 2,000.00
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Global Markets Direct
December 2019
Price: USD 2,000.00
Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
颁补迟补濒辞驳:听
Global Markets Direct
June 2021
Price: USD 2,000.00
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021 Summary...
颁补迟补濒辞驳:听
Global Markets Direct
November 2021
Price: USD 2,000.00
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Global Markets Direct
February 2018
Price: USD 2,000.00
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Global Markets Direct
April 2019
Price: USD 2,000.00
听
